You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 8,501,164


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,501,164
Title:Nicotine lozenge compositions
Abstract: The present invention relates to nicotine lozenge compositions comprising reduced levels of buffering agents from traditional nicotine lozenges and which provide optimal oral pH and prompt nicotine absorption in a smaller, more convenient dosage form.
Inventor(s): Chen; Li-Lan (Parsippany, NJ)
Assignee: GlaxoSmithKline, LLC (Philadelphia, PA)
Application Number:12/990,049
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,501,164: A Comprehensive Analysis

Introduction

Patent 8,501,164, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully understand its implications, it is crucial to delve into the specifics of the patent, the patent landscape, and the relevant legal frameworks.

Patent 8,501,164: Overview

Patent Title and Abstract

The title and abstract of the patent provide the first glimpse into what the invention is about. While the specific details of Patent 8,501,164 are not provided here, it is essential to start by reading the abstract and title to understand the general nature of the invention.

Claims

The claims section is the heart of any patent, as it defines the scope of protection granted to the inventor. There are two types of claims: independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Analyzing the Claims

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be significant metrics for measuring patent scope. Patents with narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, tend to have a higher probability of grant and a shorter examination process[3].

Claim Language and Scope

The language used in the claims is critical. It must be precise and clear to avoid ambiguity. Broader claims can lead to increased licensing and litigation costs, as they may encompass a wider range of technologies and innovations[3].

Subject Matter Eligibility Under 35 U.S.C. § 101

The Two-Pronged Framework

The United States Patent and Trademark Office (USPTO) uses a two-pronged framework to determine the subject matter eligibility of inventions under 35 U.S.C. § 101. This framework, introduced in the 2019 Revised Patent Subject Matter Eligibility Guidance (2019 PEG), is crucial for understanding whether the claims of Patent 8,501,164 are eligible for patent protection.

Prong One: Abstract Ideas

The first prong determines whether at least one claim element recites one of the enumerated groupings of abstract ideas: mathematical concepts, certain methods of organizing human activity, and mental processes. If the claim does not recite an abstract idea, it is patent-eligible. Otherwise, it proceeds to Prong Two[1].

Prong Two: Practical Application

In Prong Two, the claim is eligible if the claim elements beyond those corresponding to the alleged abstract idea integrate the abstract idea into a practical application. This can be demonstrated by showing that the claims reflect an improvement in the functioning of a computer or an improvement to other technology or technical field[1].

Practical Tips for Overcoming Section 101 Rejections

To overcome section 101 rejections, it is essential to demonstrate that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. This involves building a compelling narrative around the main novelty of the claimed invention and highlighting its practical utility and real-world impact[1].

Patent Landscape and Prior Art

Conducting a Preliminary Patent Search

To understand the patent landscape surrounding Patent 8,501,164, conducting a thorough patent search is necessary. The USPTO provides several tools, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), which can help in identifying prior art and related applications[4].

Global Dossier and Common Citation Document (CCD)

The Global Dossier and CCD applications are particularly useful for accessing the file histories of related applications and consolidating prior art cited by multiple offices. This helps in visualizing the search results for the same invention on a single page[4].

Legal and Regulatory Considerations

False Patent Claims and Lanham Act Violations

Businesses must be cautious when making claims about the patented status of their products. Falsely claiming a product or feature is patented can lead to false advertising claims under the Lanham Act, as seen in the Federal Circuit decision in Crocs, Inc. v. Effervescent, Inc.[2].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could potentially simplify and reduce the costs associated with patent litigation. However, this is still in the exploratory phase and has not been implemented[5].

Case Law and Guidance

Federal Circuit and Supreme Court Precedent

While the USPTO's guidance is important for patent examiners, it is crucial to note that the Federal Circuit and Supreme Court precedent take precedence over the USPTO's guidance. The Federal Circuit has emphasized that the USPTO’s guidance does not carry the force of law and must align with judicial caselaw[1].

Key Takeaways

  • Claims Analysis: The scope and claims of a patent are critical and must be analyzed in detail to understand the protection granted.
  • Subject Matter Eligibility: The two-pronged framework under 35 U.S.C. § 101 is essential for determining patent eligibility, especially for AI and technological innovations.
  • Patent Landscape: Conducting thorough patent searches using USPTO tools helps in identifying prior art and related applications.
  • Legal Considerations: False patent claims can lead to Lanham Act violations, and businesses must be accurate in their claims.
  • Regulatory Frameworks: Understanding the legal and regulatory environment, including potential changes like a small claims patent court, is vital for navigating the patent system.

FAQs

What is the significance of the two-pronged framework in patent eligibility?

The two-pronged framework is crucial for determining whether an invention is eligible for patent protection under 35 U.S.C. § 101. It helps in distinguishing between abstract ideas and practical applications, ensuring that only innovations with real-world impact are patented.

How can false patent claims lead to legal issues?

False patent claims can lead to false advertising claims under the Lanham Act, as seen in the Crocs, Inc. v. Effervescent, Inc. case. This can result in legal action and damage to the business's reputation.

What tools are available for conducting a preliminary patent search?

The USPTO provides several tools, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), to help in conducting thorough patent searches.

Why is it important to ensure the claims are not overly broad?

Overly broad claims can lead to increased licensing and litigation costs and may diminish the incentives for innovation. Narrower claims are associated with a higher probability of grant and a shorter examination process.

What is the current status of the small claims patent court proposal?

The proposal for a small claims patent court is still in the exploratory phase, with studies and public comments being gathered. It has not been implemented yet.

Sources

  1. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts
  2. Federal Circuit Ruling: False Patent Claims Can Lead to Lanham Act Violations - BIPC
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,501,164

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Haleon Us Holdings NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 022360-001 May 18, 2009 OTC Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Haleon Us Holdings NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 022360-002 May 18, 2009 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,501,164

PCT Information
PCT FiledApril 30, 2009PCT Application Number:PCT/US2009/042190
PCT Publication Date:November 05, 2009PCT Publication Number: WO2009/134947

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.